Versor Investments’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,898
Closed -$358K 308
2025
Q4
$358K Buy
+17,898
New +$350K 0.06% 419
2024
Q2
Sell
-32,800
Closed -$500K 819
2024
Q1
$500K Buy
32,800
+8,100
+33% +$127K 0.1% 331
2023
Q4
$396K Sell
24,700
-2,200
-8% -$30.8K 0.08% 414
2023
Q3
$349K Buy
26,900
+14,917
+124% +$194K 0.07% 435
2023
Q2
$153K Sell
11,983
-3,200
-21% -$40K 0.03% 572
2023
Q1
$171K Buy
15,183
+483
+3% +$5.86K 0.02% 654
2022
Q4
$195K Sell
14,700
-27,054
-65% -$356K 0.02% 641
2022
Q3
$485K Buy
41,754
+8,748
+27% +$120K 0.03% 462
2022
Q2
$487K Buy
33,006
+5,398
+20% +$88.4K 0.02% 487
2022
Q1
$534K Buy
+27,608
New +$493K 0.02% 306
2017
Q2
Sell
-12,500
Closed -$173K 199
2017
Q1
$173K Buy
+12,500
New +$147K 0.07% 101

Other funds holding INVA

Versor Investments's INVA Position: Q1 2026 in Review

Versor Investments sold out of Innoviva (INVA) in Q1 2026, closing a stake of 17,898 shares — an estimated $358K sold.

Versor Investments first reported a position in INVA in Q1 2017 and held it in 11 quarters. The position peaked at $534K in Q1 2022. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Versor Investments reported no remaining Innoviva position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 17,898 Innoviva shares in Q1 2026, an estimated $358K.
  • Versor Investments first reported a position in Innoviva in Q1 2017 and held it in 11 quarters.
  • Versor Investments's Innoviva position peaked at $534K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.